×
About 455,055 results

ALLMedicine™ Vaccines & Immunization Center

Research & Reviews  141,892 results

Adverse outcome and severity of COVID-19 in patients with autoimmune bullous diseases: ...
https://doi.org/10.1111/dth.15672
Dermatologic Therapy; Shirzad Moghadam F, Kianfar N et. al.

Jul 1st, 2022 - The ongoing COVID-19 pandemic has raised concerns regarding the outcome of this infection in patients with autoimmune bullous dermatoses (AIBDs) due to effect of drugs used to treat these disorders. This investigation was performed from the onset ...

SARS-CoV-2 Antibody Longitudinal Profile of Immune Globulin Preparations.
https://doi.org/10.1093/milmed/usac192
Military Medicine; Park HJ, Alcover KC et. al.

Jul 1st, 2022 - Intravenous immunoglobulin (IVIG) preparations, used for the treatment of antibody deficiencies, provide a glimpse of the general population's antibody profile as each preparation is generated from a pool of thousands of donors. The severe acute r...

Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.
https://doi.org/10.1111/irv.13024
Influenza and Other Respiratory Viruses; Tunheim G, Rø GØI et. al.

Jul 1st, 2022 - One year into the COVID-19 pandemic, the cumulative number of confirmed COVID-19 cases in Norway was still low. In January 2021, when the Norwegian COVID-19 vaccination campaign started, the national seroprevalence estimate of SARS-CoV-2 antibodie...

Antibody response to BNT162b2 mRNA vaccine in gingival crevicular fluid.
https://doi.org/10.1002/JPER.22-0152
Journal of Periodontology; Han P, Moran CS et. al.

Jul 1st, 2022 - This prospective cohort study aimed to evaluate the antibody responses in non-invasive gingival crevicular fluid (GCF) and unstimulated whole saliva to the SARS-CoV-2 Spike unit 1 receptor-binding domain (S1-RBD) protein following administration o...

see more →

Guidelines  959 results

U.S. Expands Monkeypox Vaccination Strategy
https://www.medpagetoday.com/washington-watch/washington-watch/99497
MedPage Today; Fiore K.

Jun 29th, 2022 - The U.S. is expanding its monkeypox vaccination strategy to include those with a presumed exposure to monkeypox, not just a confirmed exposure, federal officials announced Tuesday evening. The new strategy takes into account the limited doses o...

Naturally-acquired Immunity Dynamics against SARS-CoV-2 in Children and Adolescents
https://www.medrxiv.org/content/10.1101/2022.06.20.22276650v1
Medrxiv Patalon T, .

Jun 21st, 2022 - Objectives: There are paucity of studies examining naturally acquired immunity against SARS-CoV-2 in children and adolescents, though they are generally the last group to be afforded the vaccine, and a significant portion of them are still unvacci...

How common is long COVID? Why studies give different answers
https://www.nature.com/articles/d41586-022-01702-2
Nature Ledford H.

Jun 20th, 2022 - Enormous databases do not necessarily allow scientists to solve long COVID mysteries, such as how well vaccination protects against the condition.

The adverse reactions to vaccines practice parameter 10 years on-what have we learned?
https://doi.org/10.1016/j.anai.2022.03.028
Annals of Allergy, Asthma & Immunology : Official Publica... Wolfson AR

Jun 19th, 2022 - The adverse reactions to vaccines practice parameter 10 years on-what have we learned?|2022|Wolfson AR,|adverse effects,adverse effects,

see more →

Drugs  1,450 results see all →

Clinicaltrials.gov  11,301 results

U.S. Expands Monkeypox Vaccination Strategy
https://www.medpagetoday.com/washington-watch/washington-watch/99497
MedPage Today; Fiore K.

Jun 29th, 2022 - The U.S. is expanding its monkeypox vaccination strategy to include those with a presumed exposure to monkeypox, not just a confirmed exposure, federal officials announced Tuesday evening. The new strategy takes into account the limited doses o...

Natural History of Post-Coronavirus Disease 19 Convalescence at the National Institutes of Health
https://clinicaltrials.gov/ct2/show/NCT04573062

Jun 24th, 2022 - Study Description: In late 2019, the novel coronavirus SARS/CoV2 appeared in Wuhan, China. The various ways that humans will recover from COVID-19 is just starting to be observed and it is clear there will be a wide range of convalescent experienc...

Plasmodium and Other Parasites in Pregnant Women and Children Around Margibi and Montserrado Counties, Liberia
https://clinicaltrials.gov/ct2/show/NCT03719599

Jun 24th, 2022 - Malaria caused by Plasmodium falciparum continues to be a global problem with devastating consequences, in particular for at-risk populations such as pregnant women and young infants. Pregnancy malaria is associated with low birth weight (LBW), ma...

COV2Base-A Rare Disease by COVID Study
https://clinicaltrials.gov/ct2/show/NCT04564274

Jun 24th, 2022 - Study Description: This protocol will collect information on frequency and severity of COVID infection for patients with rare diseases and community controls. Study Objectives: Primary Objective: To quantify the frequency and severity of COVID inf...

Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal Cancers
https://clinicaltrials.gov/ct2/show/NCT04491955

Jun 24th, 2022 - Background: Metastatic or refractory/recurrent small bowel and colorectal cancers are incurable and poorly palliated by standard therapies. There is an unmet need for active treatments for these tumors. To date immunotherapies including anti PD-1 ...

see more →

News  25,480 results

Study Confirms Increased CVT With AstraZeneca COVID Vaccine
https://www.medscape.com/viewarticle/976487

Jul 1st, 2022 - A new Scandinavian study has confirmed previous data showing increased rates of cerebral venous thrombosis and thrombocytopenia after the AstraZeneca COVID-19 vaccine. The study also showed higher rates of several thromboembolic and thrombocytopen...

Widespread rash in toddler
https://www.mdedge.com/familymedicine/article/255882/pediatrics/widespread-rash-toddler
MDedge Family Medicine;

Jun 30th, 2022 - This patient was given a diagnosis of Gianotti Crosti syndrome (GCS; also called infantile acrodermatitis of childhood), which is a self-resolving (often dramatic) dermatosis triggered by a viral infection or immunization. Patients with this syndr.

Disease-Modifying Therapies in Progressive Multiple Sclerosis
https://www.mdedge.com/neurology/article/255818/multiple-sclerosis/disease-modifying-therapies-progressive-multiple
Robert Shin, MD

Jun 30th, 2022 - Dr Robert Shin, from Georgetown University Hospital, highlights key presentations in disease-modifying therapy for multiple sclerosis (MS) presented at the 2022 annual meeting of the Consortium of Multiple Sclerosis Centers. First, Dr Shin discuss.

US Steps Up Fight Against Monkeypox, Allocates More Vaccines to States
https://www.medscape.com/viewarticle/976347

Jun 30th, 2022 - CHICAGO/WASHINGTON (Reuters) - The U.S. government is ramping up efforts to staunch the spread of monkeypox by sending hundreds of thousands of vaccine doses to states in the coming months, expanding access for those most at risk and increasing su...

Vaccines for New COVID Variants Might Come Too Late
https://www.medscape.com/viewarticle/976441

Jun 30th, 2022 - Not surprisingly for an RNA virus, SARS-CoV-2 is proving its propensity for mutation. In swabs from infected patients, the proportion of the Omicron subvariant BA.4 is 2.1% (calendar week 21) compared with 1.2% in the previous week. In the same pe...

see more →

Patient Education  940 results see all →